Jennison Associates’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-4,169
| Closed | -$526K | – | 641 |
|
|
2020
Q1 | $526K | Buy |
+4,169
| New | +$526K | ﹤0.01% | 559 |
|
|
2019
Q3 | – | Sell |
-9,295
| Closed | -$1.32M | – | 648 |
|
|
2019
Q2 | $1.32M | Sell |
9,295
-195
| -2% | -$27.7K | ﹤0.01% | 523 |
|
|
2019
Q1 | $1.38M | Buy |
+9,490
| New | +$1.38M | ﹤0.01% | 518 |
|
|
2017
Q4 | – | Sell |
-17,241
| Closed | -$1.86M | – | 650 |
|
|
2017
Q3 | $1.86M | Buy |
+17,241
| New | +$1.86M | ﹤0.01% | 547 |
|
|
2015
Q4 | – | Sell |
-12,063
| Closed | -$766K | – | 664 |
|
|
2015
Q3 | $766K | Sell |
12,063
-106
| -0.9% | -$6.73K | ﹤0.01% | 635 |
|
|
2015
Q2 | $856K | Buy |
+12,169
| New | +$856K | ﹤0.01% | 675 |
|
|
2014
Q3 | – | Sell |
-9,685
| Closed | -$518K | – | 720 |
|
|
2014
Q2 | $518K | Buy |
+9,685
| New | +$518K | ﹤0.01% | 677 |
|
|
2013
Q4 | – | Sell |
-6,037
| Closed | -$279K | – | 709 |
|
|
2013
Q3 | $279K | Buy |
+6,037
| New | +$279K | ﹤0.01% | 677 |
|